X0306 4/A 2022-01-10 2022-01-12 0 0001359931 Protara Therapeutics, Inc. TARA 0001903622 Bandari Jathin C/O PROTARA THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 3RD FLOOR NEW YORK NY 10010 0 1 0 0 Chief Medical Officer Common Stock 21000 D On January 12, 2022, the Reporting Person filed a Form 4 which inadvertently reported that, following the issuance of a restricted stock unit award, he directly owned 13,500 shares of the Issuer's common stock. In fact, as reported in this amendment, the Reporting Person directly owned 21,000 shares of common stock. /s/ Mary Grendell, Attorney-in-Fact 2022-03-09